A therapeutic study of an adamantane spiro compound in experimental influenza A infection in man.
D000218:Adamantane / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000293:Adolescent; D000328:Adult; D001952:Bridged-Ring Compounds / Q000031:analogs & derivatives*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D009980:Influenza A virus; D007251:Influenza, Human / Q000517:prevention & control*; D008297:Male; D008875:Middle Aged; D010919:Placebos; D013141:Spiro Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D013997:Time Factors
D001952:Bridged-Ring Compounds; D010919:Placebos; D013141:Spiro Compounds; D000218:Adamantane